University of Washington Department of Laboratory Medicine and Pathology

What University of Washington Department of Laboratory Medicine and Pathology does

The University of Washington Department of Laboratory Medicine and Pathology (DLMP) is an academic department within UW Medicine, formed on July 1, 2020 through the merger of the former Department of Pathology (founded 1954) and the Department of Laboratory Medicine. The department provides comprehensive clinical diagnostic services spanning anatomic pathology, surgical pathology, clinical pathology, molecular diagnostics, microbiology, virology, immunology, flow cytometry, cytogenetics, and genetics/solid tumors testing. Service delivery is embedded in an integrated healthcare network that includes UW Medical Center (Montlake and Northwest campuses), Harborview Medical Center, Seattle Children's Hospital, the VA Puget Sound Healthcare System, Fred Hutch Cancer Center, and 14 UW Neighborhood Clinics, reaching the five-state WWAMI region (WA, WY, AK, MT, ID).

Underlying technical capabilities include proprietary systems such as the five-tiered Barrett's Esophagus diagnostic criteria framework, Luminex multiplex bead-based immunoassays for tissue proteomics, SELEX-derived oligonucleotide aptamers for novel tissue diagnostics, and collaborative formalin fixation optimization protocols developed with Ventana Medical Systems. The department operates a public-facing Online Test Guide for clinicians, a COVID-19 Virology Lab dashboard, and educational resource portals. The Virology Lab scaled to handle over 2 million COVID-19 tests since March 2020, accounting for 40% of Washington State's testing volume.

The business model combines clinical laboratory billing through UW Medicine-affiliated hospitals and clinics, research grants from NIH, the Department of Defense, and the Bill & Melinda Gates Foundation, and tuition/fees from a multi-tiered educational portfolio. Educational programs span medical student training, 56 residency/fellowship positions across 19 subspecialty fellowships, plus BS (MLS), MS, PhD (M3D program), MD/PhD (MSTP), Pathologists' Assistant, and a Certificate Program in Clinical Laboratory Leadership & Management. Leadership currently sits with Chair Dr. Geoffrey Baird (appointed July 1, 2021), overseeing 300+ faculty and 1,400+ staff.

Name

University of Washington Department of Laboratory Medicine and Pathology

Legal name

Department of Laboratory Medicine & Pathology, University of Washington

Website

https://dlmp.uw.edu

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

101–250 employees

Short description

The University of Washington Department of Laboratory Medicine and Pathology is an academic department within UW Medicine that provides comprehensive clinical diagnostic, anatomic pathology, and molecular testing services, while delivering extensive graduate medical education and conducting NIH-funded biomedical research across the five-state WWAMI region.

Ownership category

akta.pro rank

Product category

Clinical Laboratory and Pathology Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Clinical laboratory services
• Anatomic pathology services
• Molecular diagnostic testing
• Medical laboratory education
• Pathology residency training

Headquarters

HQ city

Seattle, WA

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Clinical Laboratory Services: Revenue from providing diagnostic testing services to patients and healthcare institutions across the WWAMI region
2. Research Grants and NIH Funding: Highly funded by NIH and other institutions including Department of Defense and Bill and Melinda Gates Foundation for research programs
3. Educational Programs: Tuition and fees from medical student training, residency, fellowship, MS, BS, and PhD programs

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Department of Laboratory Medicine and Pathology (DLMP) at UW Medicine delivers comprehensive clinical laboratory and anatomic pathology diagnostic testing across specialties including molecular diagnostics, microbiology, virology, immunology, flow cytometry, cytogenetics, and genetics and solid tumors. It operates as an academic medical center combining fully accredited laboratory services with biomedical research programs and graduate medical education spanning BS, MS, PhD, MD/PhD, residency, and fellowship tracks.

Product overview

The Department of Laboratory Medicine and Pathology at UW Medicine operates as an academic medical center offering integrated clinical laboratory and pathology services. The portfolio consists of diagnostic testing services (anatomic pathology, clinical pathology, molecular diagnostics, virology, immunology), supported by research capabilities and comprehensive educational programs. The department provides patient care through multiple facilities (UW Medical Center, Harborview, Seattle Children's, VA Puget Sound, Fred Hutch Cancer Center) and offers extensive graduate medical education including residency, fellowship, and degree programs (BS, MS, PhD). The department serves the five-state WWAMI region (WA, WY, AK, MT, ID) and maintains research funding from NIH, Department of Defense, and Bill and Melinda Gates Foundation. Notable digital offerings include an Online Test Guide for test ordering, COVID-19 testing dashboard for public health reporting, and educational pathology resources.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Laboratory Testing Services
• Anatomic Pathology Services
• Research Testing Service (RTS)
• Blood Draw Locations / Specimen Collection Services
• Medical Student Training
• Residency Program (AP, CP, AP/CP, AP/NP)
• Clinical Subspecialty Fellowship Programs
• MS in Laboratory Medicine
• MLS Undergraduate Program
• Molecular Medicine and Mechanisms of Disease (M3D) PhD Program
• MD/PhD Program (MSTP)
• Pathologists' Assistant Program
• Certificate Program in Clinical Laboratory Leadership & Management
• DLMP Research Flow Cytometry Core

Quantifiable outcome

• Over 2 million COVID-19 tests performed since March 2020
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and notable.

• Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerCollaborative clinical and research relationship providing oncology-focused pathology services. Joint faculty appointments and shared research programs in cancer research and virology.
• Seattle Children's HospitalcoreStrategic or Co-development PartnerPediatric pathology and clinical laboratory services partnership. Faculty members provide diagnostic services and training at the children's hospital.
• Veterans Administration Puget Sound Healthcare SystemcoreStrategic or Co-development PartnerLaboratory medicine and pathology services for veteran patients. Faculty provide clinical services and training at VA facilities.
• Stanford UniversitynotableStrategic or Co-development PartnerCollaborative research program studying cerebrospinal fluid proteins in Alzheimer's and other dementias, funded by NIH grant totaling $15.9 million over five years.
• Ventana Medical SystemsnotableTechnology or IntegrationCollaborative research studying the formalin fixation process, aimed at monitoring the process with novel methods and determining optimized fixation protocols for molecular and proteomic assays.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: Largest U.S. commercial clinical laboratory, offering routine and specialty diagnostics nationally. Broad incumbent competing on scale, menu breadth, and turnaround time rather than academic specialization.
• Sonic Healthcare: Global reference laboratory and pathology services provider with extensive anatomic pathology operations. Broad incumbent operating at comparable scale to DLMP across multiple geographies.
• Laboratory Corporation of America (Labcorp): Second-largest U.S. commercial clinical lab with national footprint across routine and specialty diagnostics, plus drug development services. Broad incumbent competing on volume and integrated services.

Direct peers

• Mayo Clinic Laboratories: The reference laboratory arm of Mayo Clinic, offering comprehensive esoteric and routine clinical diagnostics across all major pathology subspecialties. Closest direct analog to DLMP in combining academic medical-center excellence with broad commercial reference lab capabilities.
• ARUP Laboratories: A nonprofit enterprise of the University of Utah, providing reference lab services to half of all U.S. university hospitals. Direct peer as a university-affiliated clinical reference lab offering anatomic/clinical pathology and esoteric testing.
• NeoGenomics: Specialty oncology-focused clinical lab providing molecular and genetic testing for cancer. Direct peer in the high-complexity oncology pathology and molecular diagnostics segments where DLMP's Fred Hutch partnership is concentrated.
• Foundation Medicine: Specialty molecular diagnostics company focused on comprehensive genomic profiling of cancers, now part of Roche. Comparable to DLMP's genetics and solid tumors / molecular hematopathology offerings.
• Stanford Health Care Clinical Laboratories: Academic medical center clinical lab at Stanford, which is also DLMP's active research collaborator on the $15.9M NIH-funded cerebrospinal fluid proteomics program. Direct peer in academic pathology excellence and NIH funding leadership.

Regional players

• ACL Laboratories: Hospital-based clinical laboratory serving Advocate Aurora Health across Illinois and Wisconsin. Comparable as an integrated academic-health-system lab, though operating in a different region from DLMP.

Emerging players

• Exact Sciences: Molecular diagnostics company with leading position in colorectal and multi-cancer screening. Comparable to DLMP's molecular diagnostics capabilities, with a stronger commercial focus but narrower menu.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/uwlabmedpath
• YouTubeyoutube.com/c/uwlabmedpath
• LinkedInlinkedin.com/school/uwlabmedpath

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Washington Department of Laboratory Medicine and Pathology